Cargando…

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine

Several SARS-CoV-2 vaccines have received EUAs, but many issues remain unresolved, including duration of conferred immunity and breadth of cross-protection. Adjuvants that enhance and shape adaptive immune responses that confer broad protection against SARS-CoV-2 variants will be pivotal for long-te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jangra, Sonia, Landers, Jeffrey J., Rathnasinghe, Raveen, O’Konek, Jessica J., Janczak, Katarzyna W., Cascalho, Marilia, Kennedy, Andrew A., Tai, Andrew W., Baker, James R., Schotsaert, Michael, Wong, Pamela T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481386/ https://www.ncbi.nlm.nih.gov/pubmed/34603303 http://dx.doi.org/10.3389/fimmu.2021.729189

Ejemplares similares

A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Immunomodulation of T(H)2 biased immunity with mucosal administration of nanoemulsion adjuvant
por: Bielinska, Anna U., et al.
Publicado: (2016)

Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens
por: Farazuddin, Mohammad, et al.
Publicado: (2021)

Nanoemulsion Adjuvant Augments Retinaldehyde Dehydrogenase Activity in Dendritic Cells via MyD88 Pathway
por: Farazuddin, Mohammad, et al.
Publicado: (2019)

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)

The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Retinoic Acid Signaling Is Required for Dendritic Cell Maturation and the Induction of T Cell Immunity
por: Farazuddin, Mohammad, et al.
Publicado: (2023)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

The unfulfilled potential of mucosal immunization
por: Baker, James R., et al.
Publicado: (2022)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
por: Chang, Lauren A., et al.
Publicado: (2023)

Intranasal immunization with W(80)5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model
por: Passmore, Crystal, et al.
Publicado: (2014)

Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants
por: Wong, Pamela T., et al.
Publicado: (2015)

Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut Allergy
por: Hughes, Kevin R., et al.
Publicado: (2022)

Editorial: Food allergy: advances in basic and translational animal models
por: Dolence, Joseph J., et al.
Publicado: (2023)

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2020)

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
por: Nogales, Aitor, et al.
Publicado: (2021)

Unrepairable DNA Double Strand Breaks Initiate Cytotoxicity with HSV-TK/Ganciclovir
por: Ladd, Brendon, et al.
Publicado: (2011)

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2021)

Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria
por: Raveh, Avi, et al.
Publicado: (2013)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

38227 Specific and highly potent human monoclonal antibodies against SARS-CoV-2
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
por: White, Kris M., et al.
Publicado: (2021)

MLH1 Deficiency Enhances Tumor Cell Sensitivity to Ganciclovir
por: O’Konek, Jessica J., et al.
Publicado: (2009)

Secondary Rearrangements and Hypermutation Generate Sufficient B Cell Diversity to Mount Protective Antiviral Immunoglobulin Responses
por: López-Macías, Constantino, et al.
Publicado: (1999)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant
por: Tendler, Miriam, et al.
Publicado: (2015)

The rate of mutation of a single gene
por: Balin, Samuel J., et al.
Publicado: (2010)

IgM in the Kidney: A Multiple Personality Disorder
por: Platt, Jeffrey L., et al.
Publicado: (2015)

Cell Fusion in Malignancy: A Cause or Consequence? A Provocateur or Cure?
por: Platt, Jeffrey L., et al.
Publicado: (2019)

Challenges and potentials of xenotransplantation
por: Cascalho, Marilia, et al.
Publicado: (2008)

TNFRSF13B Diversification Fueled by B Cell Responses to Environmental Challenges—A Hypothesis
por: Cascalho, Marilia, et al.
Publicado: (2021)

TNFRSF13B in B cell responses to organ transplantation
por: Cascalho, Marilia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_393460gjn2j97qqup6m2dkgiso